Hello, Fool! | Login | Signup | My Fool
Oct 11, 2008 2:01 PM ET | Feedback | Site Changes | Help
The Company discovers, develops, manufactures and markets medical therapies and treatments to enhance human health.
View All Commentary (SGP)
Recs
Gumpster (94.70) Submitted: 12/05/06 1:47 AM : Start Price: $22.29 SGP Score: -3.13
Fred Hassan appears to have stabilized the ship and put it on track to continued success. The company's earnings appear somewhat depressed due to continued heavy R&D spending; continues sales growth should offer meaningful leverage. The fundamentals look good and there's a chance industry consolidation could help out even more.
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.